Medical Director, AstraZeneca Hong Kong Limited
Dr. Choon-Kiat TAN is a commercially-savvy medical director with broad-based experience and a global outlook. He is currently the Medical Director of AstraZeneca Hong Kong Limited, responsible for all medical affairs and regulatory affairs matters in the company.
Dr. Tan’s professional experience includes clinical practice, strategy consulting and pharmaceutical medicine. Upon graduating from medical school, Dr. Tan started his career practising medicine in the various healthcare institutions in Singapore. He then joined the Singapore Economic Development Board and was part of the team that formulated the strategies and plans for developing Singapore into the global biomedical hub we see today.
Post-business school, Dr. Tan took on a strategy consulting role based in London, first with Deloitte Consulting and then with Dell Perot, working on various strategic and operational projects, including commercial due diligence as part of merger and acquisition deals. He also reviewed, proposed, and implemented changes in the U.K National Health Services that generated potential savings of £20 million. More recently, he joined the pharmaceutical industry, taking on regional leadership roles covering the Asia Pacific region, first with Merck Serono and then with Roche Diagnostics.
Dr. Tan has lived and worked in the United Kingdom, Qatar, Abu Dhabi, China and the Asia-Pacific region. Dr Tan earned his bachelors medical degree (MBBS) from the National University of Singapore and his post-graduate business degree (MBA) from INSEAD, France.